We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Awareness Technology, Inc.

Awareness Technology, Inc. provides clinical laboratory instrumentation, reagents and assays for small-to-medium-volu... read more Featured Products: More products

Download Mobile App





Awareness Technology Announces Availability of Two-Plate ELISA and Chemiluminescent Analyzer

By LabMedica International staff writers
Posted on 15 Jun 2020
Awareness Technology, Inc. More...
(Palm City, Florida, USA) has announced the availability of ChemWell 2, its two-probe, two-plate automatic combo analyzer for ELISA and chemiluminescent (CLIA).

Awareness Technology, an international IVD company, develops, manufactures, and markets in-vitro diagnostic instrumentation and diagnostic test kits, including biochemistry, ELISA, chemiluminescence, imaging analytics, electrolyte instruments, and supportive equipment. The company’s test kit portfolio includes ELISA kits for autoimmune and infectious disease testing, biochemistry test kits (for export only), allergy screening products, and instrument QC verification materials.

For 20 years, the company has produced single plate ChemWell automatic ELISA and CLIA systems with the flexibility to run both modes simultaneously even within the same plate. With laboratories expanding serology requirements, the two-plate system is expected to be a more suitable primary instrument for lower throughput labs, and ideal for off-line assays in higher throughput settings.

The key to automating a wide variety of unrelated test methods is ChemWell’s flexibility in both hardware and software. Separate probes are used for samples and reagents with an option for disposable tips. Filters range from 405 nm – 630 nm; dispense volume from 2µL to 1.95 ml; plate washing routines, temperature control, and mixing are programmable. Intuitive software offers on-board pre-dilutions, multiple calibration options, replicates, statistics, QC tracking, bar-coded sample ID and data management. It even schedules assays to prevent timing conflicts while providing optimal throughput. An optional laptop stand conserves bench space.



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Online QC Software
Acusera 24•7
New
Automated Urinalysis Solution
UN-9000
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Research team leader Professor Klaus Gerwert and study lead author Dr. Grischa Gerwert in a betaSENSE laboratory (Photo courtesy of Dennis Yenmez/Stadt Bochum)

Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s

Alzheimer’s disease and Parkinson’s disease are increasing as populations age, yet diagnosis remains largely symptom-driven and often occurs after irreversible brain damage has begun. Earlier detection,... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.